SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001570562-24-000016
Filing Date
2024-02-09
Accepted
2024-02-09 18:35:53
Documents
1
Period of Report
2024-02-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1707521743.html 4  
1 FORM 4 wk-form4_1707521743.xml 4 9072
  Complete submission text file 0001570562-24-000016.txt   10570
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Issuer) CIK: 0001570562 (see all company filings)

IRS No.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O OBALON THERAPEUTICS, INC. 5421 AVENIDA ENCINAS, SUITE F CARLSBAD CA 92008
Business Address
MOATAZEDI DAVID (Reporting) CIK: 0001700836 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38381 | Film No.: 24616903